Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Feb;63(2):472–477. doi: 10.1128/iai.63.2.472-477.1995

Protection of gerbils from amebic liver abscess by immunization with recombinant Entamoeba histolytica 29-kilodalton antigen.

C J Soong 1, B E Torian 1, M D Abd-Alla 1, T F Jackson 1, V Gatharim 1, J I Ravdin 1
PMCID: PMC173019  PMID: 7822012

Abstract

The goal of our study was to obtain a highly conserved Entamoeba histolytica recombinant antigen for study as a subunit amebiasis vaccine. We screened a Uni-Zap cDNA library of E. histolytica (strain HM1:IMSS) with human immune sera and isolated a dominant 804-bp cDNA clone. A 33-kDa fusion protein expressed from the cDNA clone was determined by monoclonal antibody binding, DNA hybridization, and nucleotide sequence to be the complete E. histolytica 29-kDa antigen. Serum antibodies to the recombinant protein were detected by enzyme-linked immunosorbent assay in 80% of subjects from Egypt and South Africa with amebic liver abscess. Similar results were found with the native 29-kDa protein. Native and recombinant 29-kDa antigens induced proliferation of lymphocytes harvested from patients with amebic liver abscess (P < 0.01 compared with controls). Intraperitoneal immunization of gerbils with the recombinant fusion protein (10 micrograms) with Titermax adjuvant elicited an antigen-specific serum immunoglobulin G antibody response and was partially protective (54%) against intrahepatic challenge with 5 x 10(5) virulent axenic trophozoites (strain HM1:IMSS). In summary, the recombinant form of the E. histolytica 29-kDa antigen demonstrated serologic specificity for amebic liver abscess, exhibited conserved T-cell epitopes, and was effective as a subunit vaccine in an experimental animal model of amebic liver abscess.

Full Text

The Full Text of this article is available as a PDF (230.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bruchhaus I., Tannich E. Analysis of the genomic sequence encoding the 29-kDa cysteine-rich protein of Entamoeba histolytica. Trop Med Parasitol. 1993 Jun;44(2):116–118. [PubMed] [Google Scholar]
  2. Chadee K., Meerovitch E. The pathogenesis of experimentally induced amebic liver abscess in the gerbil (Meriones unguiculatus). Am J Pathol. 1984 Oct;117(1):71–80. [PMC free article] [PubMed] [Google Scholar]
  3. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  4. Cieslak P. R., Virgin H. W., 4th, Stanley S. L., Jr A severe combined immunodeficient (SCID) mouse model for infection with Entamoeba histolytica. J Exp Med. 1992 Dec 1;176(6):1605–1609. doi: 10.1084/jem.176.6.1605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Edman U., Meraz M. A., Rausser S., Agabian N., Meza I. Characterization of an immuno-dominant variable surface antigen from pathogenic and nonpathogenic Entamoeba histolytica. J Exp Med. 1990 Sep 1;172(3):879–888. doi: 10.1084/jem.172.3.879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Flores B. M., Batzer M. A., Stein M. A., Petersen C., Diedrich D. L., Torian B. E. Structural analysis and demonstration of the 29 kDa antigen of pathogenic Entamoeba histolytica as the major accessible free thiol-containing surface protein. Mol Microbiol. 1993 Mar;7(5):755–763. doi: 10.1111/j.1365-2958.1993.tb01166.x. [DOI] [PubMed] [Google Scholar]
  7. Flores B. M., Reed S. L., Ravdin J. I., Torian B. E. Serologic reactivity to purified recombinant and native 29-kilodalton peripheral membrane protein of pathogenic Entamoeba histolytica. J Clin Microbiol. 1993 Jun;31(6):1403–1407. doi: 10.1128/jcm.31.6.1403-1407.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hawkes R. The dot immunobinding assay. Methods Enzymol. 1986;121:484–491. doi: 10.1016/0076-6879(86)21048-4. [DOI] [PubMed] [Google Scholar]
  9. Kafatos F. C., Jones C. W., Efstratiadis A. Determination of nucleic acid sequence homologies and relative concentrations by a dot hybridization procedure. Nucleic Acids Res. 1979 Nov 24;7(6):1541–1552. doi: 10.1093/nar/7.6.1541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Petri W. A., Jr, Chapman M. D., Snodgrass T., Mann B. J., Broman J., Ravdin J. I. Subunit structure of the galactose and N-acetyl-D-galactosamine-inhibitable adherence lectin of Entamoeba histolytica. J Biol Chem. 1989 Feb 15;264(5):3007–3012. [PubMed] [Google Scholar]
  11. Petri W. A., Jr, Smith R. D., Schlesinger P. H., Murphy C. F., Ravdin J. I. Isolation of the galactose-binding lectin that mediates the in vitro adherence of Entamoeba histolytica. J Clin Invest. 1987 Nov;80(5):1238–1244. doi: 10.1172/JCI113198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ravdin J. I., Jackson T. F., Petri W. A., Jr, Murphy C. F., Ungar B. L., Gathiram V., Skilogiannis J., Simjee A. E. Association of serum antibodies to adherence lectin with invasive amebiasis and asymptomatic infection with pathogenic Entamoeba histolytica. J Infect Dis. 1990 Sep;162(3):768–772. doi: 10.1093/infdis/162.3.768. [DOI] [PubMed] [Google Scholar]
  13. Reed S. L., Flores B. M., Batzer M. A., Stein M. A., Stroeher V. L., Carlton J. E., Diedrich D. L., Torian B. E. Molecular and cellular characterization of the 29-kilodalton peripheral membrane protein of Entamoeba histolytica: differentiation between pathogenic and nonpathogenic isolates. Infect Immun. 1992 Feb;60(2):542–549. doi: 10.1128/iai.60.2.542-549.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Robinson M., Lilley R., Little S., Emtage J. S., Yarranton G., Stephens P., Millican A., Eaton M., Humphreys G. Codon usage can affect efficiency of translation of genes in Escherichia coli. Nucleic Acids Res. 1984 Sep 11;12(17):6663–6671. doi: 10.1093/nar/12.17.6663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Salata R. A., Martinez-Palomo A., Murray H. W., Conales L., Trevino N., Segovia E., Murphy C. F., Ravdin J. I. Patients treated for amebic liver abscess develop cell-mediated immune responses effective in vitro against Entamoeba histolytica. J Immunol. 1986 Apr 1;136(7):2633–2639. [PubMed] [Google Scholar]
  16. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Stanley S. L., Jr, Becker A., Kunz-Jenkins C., Foster L., Li E. Cloning and expression of a membrane antigen of Entamoeba histolytica possessing multiple tandem repeats. Proc Natl Acad Sci U S A. 1990 Jul;87(13):4976–4980. doi: 10.1073/pnas.87.13.4976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Studier F. W., Rosenberg A. H., Dunn J. J., Dubendorff J. W. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 1990;185:60–89. doi: 10.1016/0076-6879(90)85008-c. [DOI] [PubMed] [Google Scholar]
  19. Tachibana H., Ihara S., Kobayashi S., Kaneda Y., Takeuchi T., Watanabe Y. Differences in genomic DNA sequences between pathogenic and nonpathogenic isolates of Entamoeba histolytica identified by polymerase chain reaction. J Clin Microbiol. 1991 Oct;29(10):2234–2239. doi: 10.1128/jcm.29.10.2234-2239.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Tachibana H., Kobayashi S., Kato Y., Nagakura K., Kaneda Y., Takeuchi T. Identification of a pathogenic isolate-specific 30,000-Mr antigen of Entamoeba histolytica by using a monoclonal antibody. Infect Immun. 1990 Apr;58(4):955–960. doi: 10.1128/iai.58.4.955-960.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Torian B. E., Flores B. M., Stroeher V. L., Hagen F. S., Stamm W. E. cDNA sequence analysis of a 29-kDa cysteine-rich surface antigen of pathogenic Entamoeba histolytica. Proc Natl Acad Sci U S A. 1990 Aug;87(16):6358–6362. doi: 10.1073/pnas.87.16.6358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Walsh J. A. Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Rev Infect Dis. 1986 Mar-Apr;8(2):228–238. doi: 10.1093/clinids/8.2.228. [DOI] [PubMed] [Google Scholar]
  23. Zhang T., Cieslak P. R., Stanley S. L., Jr Protection of gerbils from amebic liver abscess by immunization with a recombinant Entamoeba histolytica antigen. Infect Immun. 1994 Apr;62(4):1166–1170. doi: 10.1128/iai.62.4.1166-1170.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Zhang T., Stanley S. L., Jr Protection of gerbils from amebic liver abscess by immunization with a recombinant protein derived from the 170-kilodalton surface adhesin of Entamoeba histolytica. Infect Immun. 1994 Jun;62(6):2605–2608. doi: 10.1128/iai.62.6.2605-2608.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES